相关实验视频

Updated: Jan 16, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.5K

在RSV免疫预防的进步:进化,有效性和实施挑战.

Faris Al Gharaibeh1,2, Ved Deshmukh2, Hitesh Deshmukh1,2

  • 1Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

NeoReviews
|September 30, 2025
PubMed
概括

新的呼吸道同胞病毒 (RSV) 预防策略,包括先进的抗体和母体疫苗,在减少婴儿住院治疗方面显示出70%以上的有效性. 实施需要解决全球获取和医疗保健提供挑战.

更多相关视频

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.0K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.3K

相关概念视频

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
790